The Ethos Clinical School is a comprehensive two and a half day training program designed to credential physicians, physicists, therapists, and dosimetrists in adaptive radiotherapy using the Varian ...
PALO ALTO, Calif., Feb. 11, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Ethos™ therapy, an Adaptive Intelligence™ solution. Ethos therapy is an ...
SYDNEY, April 2, 2020 /PRNewswire/ -- The Icon Cancer Centre Wahroonga in Australia has treated its first cancer patient with Varian Ethos™. This artificial intelligence (AI)-driven holistic adaptive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results